Select a result to preview

National Immunisation Schedule

← Back to Index (⭕ Misc)

Universal Immunisation Programme (UIP) - Ministry of Health & Family Welfare, Government of India
(Updated for 2026; core schedule unchanged from 2025 with nationwide HPV rollout for adolescent girls)

Age / Group Vaccine Dose Route Site Diseases Protected Against Notes / Remarks
Pregnant Women Td-1 (Tetanus + Diphtheria) 0.5 ml Intramuscular (IM) Upper arm Tetanus, Diphtheria As early as possible in pregnancy
Pregnant Women Td-2 0.5 ml IM Upper arm Tetanus, Diphtheria 4 weeks after Td-1
Pregnant Women Td-Booster 0.5 ml IM Upper arm Tetanus, Diphtheria If 2 doses received in previous pregnancy within last 3 years
At Birth BCG 0.05 ml (up to 1 month) / 0.1 ml Intradermal (ID) Left upper arm Tuberculosis (severe forms) Within 24-72 hours of birth
At Birth bOPV-0 (Oral Polio) 2 drops Oral - Poliomyelitis (types 1 & 3) Within 15 days of birth
At Birth Hepatitis B (Birth dose) 0.5 ml IM Anterolateral mid-thigh Hepatitis B Preferably within 24 hours
6 Weeks bOPV-1 2 drops Oral - Poliomyelitis -
6 Weeks fIPV-1 (Fractional Inactivated Polio) 0.1 ml ID Right upper arm Poliomyelitis -
6 Weeks Pentavalent-1 0.5 ml IM Anterolateral mid-thigh Diphtheria, Pertussis, Tetanus, Hepatitis B, Hib (meningitis & pneumonia) -
6 Weeks Rotavirus-1 (RVV-1) 5 drops (liquid) Oral - Rotavirus diarrhoea -
6 Weeks PCV-1 (Pneumococcal Conjugate) 0.5 ml IM Anterolateral mid-thigh Pneumococcal pneumonia & meningitis Phased introduction (selected states/districts)
10 Weeks bOPV-2 2 drops Oral - Poliomyelitis -
10 Weeks Pentavalent-2 0.5 ml IM Anterolateral mid-thigh Diphtheria, Pertussis, Tetanus, Hepatitis B, Hib -
10 Weeks Rotavirus-2 5 drops Oral - Rotavirus diarrhoea -
14 Weeks bOPV-3 2 drops Oral - Poliomyelitis -
14 Weeks Pentavalent-3 0.5 ml IM Anterolateral mid-thigh Diphtheria, Pertussis, Tetanus, Hepatitis B, Hib -
14 Weeks Rotavirus-3 5 drops Oral - Rotavirus diarrhoea -
14 Weeks fIPV-2 0.1 ml ID Right upper arm Poliomyelitis -
9-11 Months MR-1 (Measles + Rubella) 0.5 ml Subcutaneous (SC) Right upper arm Measles, Rubella -
9-11 Months JE-1 (Japanese Encephalitis) 0.5 ml SC / IM As per vaccine Japanese Encephalitis Endemic districts only
9-11 Months Vitamin A (1st dose) 1 ml (1 lakh IU) Oral - Vitamin A deficiency Given with MR-1
9-11 Months PCV Booster 0.5 ml IM Anterolateral mid-thigh Pneumococcal diseases Phased
9-11 Months fIPV-3 (if required in schedule) 0.1 ml ID Right upper arm Poliomyelitis As per state protocol
16-24 Months DPT Booster-1 0.5 ml IM Anterolateral mid-thigh Diphtheria, Pertussis, Tetanus -
16-24 Months bOPV Booster 2 drops Oral - Poliomyelitis -
16-24 Months MR-2 0.5 ml SC Right upper arm Measles, Rubella -
16-24 Months JE-2 0.5 ml SC / IM As per vaccine Japanese Encephalitis Endemic districts only
16-24 Months Vitamin A (2nd dose) 2 ml (2 lakh IU) Oral - Vitamin A deficiency -
2-5 Years TCV (typhoid conjugate vaccine) 0.5 IM anterolateral mid-thigh Typhoid
5-6 Years DPT Booster-2 0.5 ml IM Upper arm Diphtheria, Pertussis, Tetanus School entry booster
10 Years Td (Tetanus + Diphtheria) 0.5 ml IM Upper arm Tetanus, Diphtheria -
16 Years Td 0.5 ml IM Upper arm Tetanus, Diphtheria -
9-14 Years (Girls) HPV (Human Papillomavirus) 1 or 2 doses (as per age) IM Upper arm Cervical cancer & other HPV-related cancers New nationwide rollout in 2026 (single-dose campaign for 14-year cohort + routine for 9-14 years)